(7S) -BAY-593
(7S) -BAY-593 is the S-enantiomer of BAY-593 (HY-161573) . BAY-593 is an orally active GGTase-I inhibitor. BAY-593 can block YAP1/TAZ signaling in animals and has antitumor activity[1].
Product Specifications
CAS Number
[2413068-25-2]
UNSPSC
12352005
Target
GGTase; YAP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/7s-bay-593.html
Purity
99.61
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N1CCC2(CCNC[C@]2([H])C3=CC=CC=C3OC)CC1)[C@@](OC)(C(F)(F)F)C4=CC=CC=C4
Molecular Formula
C26H31F3N2O3
Molecular Weight
476.53
References & Citations
[1]Graham K, et al. Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling. Cell Chem Biol. 2024 Mar 19:S2451-9456 (24) 00087-4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GGTase I; YAP/TAZ-TEAD
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TRC-C384900-500MG 500 mg
5-Chloro-N-[2-oxo-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide
Ask
View Details MBS6199529-01 0.1 mL
ANGPTL1 (ANG3, ANGPT3, ARP1, Angiopoietin-related Protein 1, Angiopoietin-3, Angiopoietin-like Protein 1, AngY, dJ595C2.2, KIAA0351, PSEC0154, UNQ162, UNQ162/PRO188) (MaxLight 490)
Ask
View Details